The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies

Affiliations

• ¹ Department of Dermatology and Venereology, University Hospital of Cologne, Kerpener Straße 62, Köln, 50937, Germany. nico.hunzelmann@uni-koeln.de.
• ² Department of Rheumatology and Clinical Immunology, University of Berlin, Charité, Berlin, Germany.
• ³ Department of Dermatology and Venereology, University Hospital of Cologne, Kerpener Straße 62, Köln, 50937, Germany.
• ⁴ Helios St Elisabeth Clinic, Dermatology and Venereology, Oberhausen, Germany.
• ⁵ University Medical Center Freiburg, Clinical Research Unit for Rheumatology, Freiburg, Germany.
• ⁶ Justus Liebig University Giessen, Kerckhoff Clinic, Rheumatology and Clinical Immunology, Bad Nauheim, Germany.
• ⁷ Department of Dermatology and Venereology, University of Berlin, Charité, Berlin, Germany.
• ⁸ Department of Dermatology and Department of Translational Dermatoinfectiology, University of Muenster, Muenster, Germany.
• ⁹ University Hospital Ulm, Dermatology, Ulm, Germany.
• ¹⁰ Department of Dermatology, University of Tübingen, Tübingen, Germany.
• ¹¹ Department of Rheumatology, University of Tübingen, Tübingen, Germany.
• ¹² Johanniter Hospital Treuenbrietzen, Rheumatology, Treuenbrietzen, Germany.
• ¹³ Hamburg Alstertal, Clinic for Dermatology, Hamburg, Germany.
• ¹⁴ University Hospital Carl Gustav Carus, Dermatology, Dresden, Germany.
• ¹⁵ Ludwig Maximilian University, Dermatology and Allergology, Munich, Germany.
• ¹⁶ Goethe-University Frankfurt & Clinical Research, Fraunhofer IME, Translational Medicine and Pharmacology (TMP), Rheumatology, Frankfurt/Main, Germany.
• ¹⁷ Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Kerpener Straße 62, 50937, Köln, Germany.